101
Views
8
CrossRef citations to date
0
Altmetric
Commentary

The treatment of urinary incontinence with Duloxetine

&
Pages 166-169 | Published online: 02 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Steinar Hunskaar & Lina Kristin Welle-Nilsen. (2010) The market lifecycle of duloxetine for urinary incontinence in Norway. Acta Obstetricia et Gynecologica Scandinavica 89:2, pages 217-222.
Read now

Articles from other publishers (6)

Bianca Codrina Morarasu, Adorata Elena Coman, Cristina Bologa, Catalina Lionte, Ovidiu Rusalim Petris, Alexandr Ceasovschih, Victorita Sorodoc, Raluca Ecaterina Haliga, Gabriela Puha, Alexandra Stoica, Oana Sirbu, Mihai Constantin & Laurentiu Sorodoc. (2022) Recognition and Management of Serotonin Toxidrome in the Emergency Department—Case Based Review. Journal of Personalized Medicine 12:12, pages 2069.
Crossref
Aswini Balachandran & Jonathan Duckett. (2016) The efficacy and tolerability of mirabegron in a non-trial clinical setting. European Journal of Obstetrics & Gynecology and Reproductive Biology 200, pages 63-67.
Crossref
Priya Padmanabhan & Roger Dmochowski. 2011. Practical Urology: Essential Principles and Practice. Practical Urology: Essential Principles and Practice 437 451 .
Magnhild Hendset, Espen Molden, Torill Bakko Enoksen, Helge Refsum & Monica Hermann. (2010) The Effect of Coadministration of Duloxetine on Steady-State Serum Concentration of Risperidone and Aripiprazole: A Study Based on Therapeutic Drug Monitoring Data. Therapeutic Drug Monitoring 32:6, pages 787-790.
Crossref
M. Oelke, M. Seidler, S. Ückert & A. Gabuev. (2009) Wie sinnvoll ist die medikamentöse Therapie der Belastungsinkontinenz?Is medical therapy useful in the management of stress urinary incontinence?. Der Urologe 48:3, pages 228-232.
Crossref
Miles BergerJohn A. GrayBryan L. Roth. (2009) The Expanded Biology of Serotonin. Annual Review of Medicine 60:1, pages 355-366.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.